In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

dupe deal - Gilead, Royalty Pharma pay Emory for Emtriva royalties

Executive Summary

Gilead Sciences and Royalty Pharma have purchased from Emory University the royalty interest associated with worldwide net sales of Emtriva (emtricitabine) for $341.25mm (65%) and $183.75mm (35%), respectively.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies